Date | Open(₹) | High(₹) | Low(₹) | Close(₹) | No. Of Trades(₹) | Total Turnover(₹) | Deliverable Quantity(₹) |
|---|---|---|---|---|---|---|---|
31-Jul-2025 | 682 | 704 | 675 | 688.9 | 17,469 | 29,59,18,902.95 | 1,52,729 |
01-Aug-2025 | 689.1 | 694.35 | 660 | 665.35 | 18,019 | 22,55,13,866.05 | 1,31,393 |
04-Aug-2025 | 665.5 | 699.95 | 664.85 | 696.5 | 26,698 | 38,84,65,442 | 1,44,054 |
05-Aug-2025 | 696.5 | 704.1 | 670.55 | 676.3 | 14,878 | 17,63,75,972.2 | 94,363 |
06-Aug-2025 | 671.95 | 679 | 641 | 647.1 | 20,173 | 25,33,62,479.9 | 1,57,140 |
07-Aug-2025 | 642 | 671 | 640 | 667.55 | 14,716 | 18,41,31,923.55 | 1,04,970 |
08-Aug-2025 | 672 | 672 | 649.95 | 652.4 | 8,991 | 12,49,86,220.5 | 40,107 |
11-Aug-2025 | 657.75 | 671.1 | 632.05 | 661.8 | 13,966 | 17,56,09,619.7 | 1,06,714 |
12-Aug-2025 | 654 | 676.35 | 654 | 673.05 | 10,243 | 13,22,91,058.15 | 93,679 |
13-Aug-2025 | 681 | 686.95 | 663.5 | 680.35 | 13,131 | 20,54,55,285.95 | 1,16,030 |
14-Aug-2025 | 686 | 698.15 | 672.4 | 675.25 | 11,544 | 17,65,35,585 | 1,10,842 |
18-Aug-2025 | 685 | 703.55 | 675.1 | 696.75 | 15,530 | 20,96,02,413.8 | 1,37,326 |
19-Aug-2025 | 696.6 | 706 | 685.4 | 699.5 | 14,285 | 20,37,98,624.9 | 1,21,141 |
20-Aug-2025 | 704 | 719 | 681 | 711.85 | 24,876 | 45,56,93,283.75 | 2,36,029 |
21-Aug-2025 | 712 | 716 | 694 | 698.35 | 11,697 | 17,07,96,051.9 | 1,17,240 |
22-Aug-2025 | 698 | 737.85 | 692 | 724.25 | 29,693 | 54,59,38,779 | 2,81,819 |
25-Aug-2025 | 729.5 | 735 | 715.1 | 717.85 | 14,055 | 17,48,55,839.2 | 1,15,354 |
26-Aug-2025 | 720 | 725.9 | 703.35 | 707.25 | 14,836 | 21,18,72,863.4 | 83,986 |
28-Aug-2025 | 707.25 | 709.2 | 688.3 | 697.95 | 19,866 | 20,63,27,469.45 | 1,55,069 |
29-Aug-2025 | 697.95 | 712.65 | 675 | 690.15 | 20,851 | 18,31,98,949.2 | 1,15,243 |
Senores Pharmaceuticals intends to fund the acquisition through proceeds from its IPO, which raised ₹5.82 billion in December.
Senores Pharmaceuticals shares closed 6% below their listing price, although they are still up 43% from the IPO price.
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2025, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016, BSE Enlistment Number (RA): 5016
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
